Skip to main content
# Title Department Research Member Research Year
401 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
402 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
403 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2019
404 Sensitvity of flowcytometry immunphenotyping compared to Bone marrow morphology in diagnosis of multiple myeloma Department of Clinical Pathology Dr. Shimaa Gafer Mansour Hasan 2019
405 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
406 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
407 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Clinical Pathology Assmaa Ahmed Mohamed 2019
408 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Clinical Pathology Dr. Noha gaber sayed 2019
409 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute
Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2019
410 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019